Events

7th European Pharma Licensing Symposium (EPLS)

Event Details

Location: Prague, Czech Republic
Dates: Tuesday 23rd September to Wednesday 24th September 2014

The 7th EPLS took place in Prague from 22nd-24th September 2014. Over 150 companies from across Europe and the USA attended the two days of presentations, which included for the first time the ‘talking table’ format that featured 8 tables on deals issues, from Performance Issues to Deal Trends.

There was plenty of time for networking throghout the event, with a welcome drinks reception held on Monday evening and then a gala dinner at the stunning Francouzská Restaurant.

All delegates will continue to have acess to use the online delegate contact system until the end of November.

PDF copies of those presentations that we have permission to make available to delegates are available HERE

Send a message to another attendee of this event

Please enter your email address* and the password provided by PLG to send a message.

* Please enter the email address used to register for this event.

Event Sponsors


Evaluate Bronze Sponsor	SAJA Pharmaceuticals Bronze Sponsor

Event Gallery

Event Schedule

Monday 22nd September

18.30 - 20.30

Welcome Drinks Reception
Marriott Prague - Bohemia Room Function Area

Tuesday 23rd September

08.00 - 09.00	Registration
09.00 - 09.15	Welcome Address & Introduction Thomas Hoegn, EPLC Alexandr Krajhanzl, PLG CEE
SESSION A	Keynote Presentations
09.15 - 09.45	A Commercial Overview of the Opportunities in Europe Frederic Desdouits EVP Head of Corporate Business Development, Acquisitions & Marketin Intelligence Pierre Fabre
09.45 - 10.15	Are All the Emerging Markets Paying Their Way? Reiner Christensen President Chameleon Pharma Consulting
10.15 - 10.45	New Business Models - Interface with Pharma Manuela Mueller-Gerndt HCL Technologies
10.45 - 11.15	Break
SESSION B	European Entry Strategy
11.15 - 12.30	Launch Strategy for Europe with Panel Discussion: Germany - Burkhard Straeter, Strater Life Sciences UK - Dominic Hornblow, Head of Legal, UK Marketing Company, AstraZeneca Spain - Rafael Cabrera, Director Business Development and Market Access, UCB Iberia France - Julie Spiesser, Senior Director, Global Strategic Pricing, Sanofi
12.30 - 13.00	Role of HTA in Assessing BD Opportunities and Deals Monique Martin VP and General Manager, HEOR Operations Europe, Life Sciences Optum
13.00 - 14.30	Lunch
SESSION C	Talking Tables on Deal Issues
	1. Legal Aspects e.g. Termination Constanze Ulmer-Eilfort Baker & McKenzie 2. IP Aspects, e.g. SPC's Gerda Redl REDL Life Science Patent Attorneys 3. Regulatory Aspects Ulrich Granzer Granzer Regulatory Consulting & Services 4. Performance Issues in Agreements Paul Ranson & Stuart Richards Pinsent Masons 5. Deal Trends Roger Davies Medius Associates 6. Commerical Issues Thomas Hoegn TH Consulting 7. Due Diligence Issues Irina Staatz-Granzer Staatz Business Development & Strategy 8. Market Forecasting Neil Jamieson, Evaluate & Lisa Urquhart, EP Vantage
14.30 - 15.05	Individual Tables - Round 1
15.05 - 15.20	Break
15.20 - 15.50	Individual Tables - Round 2
15.50 - 17.00	Feedback to Main Group from Table Hosts
18.00 - 22.00	Networking Drinks Reception & Gala Dinner Francouzska Restaurant, Municipal House

Wednesday 24th September

SESSION D	Orphan Drugs
09.00 - 09.30	Regulatory Challenges and Threats in Orphan Drug Development - are Ultra Orphans Easy Ulrich Granzer Granzer Regulatory Consulting
09.30 - 10.00	Building by Acquisition Charlie Alexander Senior Director Business Development Shire Pharmaceuticals
10.00 - 10.30	Derisking Rare Disease Projects Chris Adams CEO Cydan Development
10.30 - 11.00	Break
SESSION E	Local Emerging / Existing Market Issues
11.00 - 11.30	Overview of Local Markets Hynek Valerian Senior Manager, Offering Management, Czech and Slovak Republics IMS Health
11.30 - 12.00	Entering the Market - Challenges and Opportunities Gyorgy Leitner Chief Operating Officer MediFood
12.00 - 12.30	Generics Transition Jerome Silvestre Senior Vice President Sanofi Global Generics Division
12.30 - 13.00	IP Issues in CEE Gerda Redl Patent and Trademark Attorney REDL Life Science Patent Attorneys
13.00 - 14.00	Lunch and Close

You must be logged in to access the downloads.